Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
The New England Journal of Medicine
|
June 2, 2016
Therapy for Tuberculous Meningitis
Praveen Sudhindra, John Nowakowski
Wiener Klinische Wochenschrift
|
January 16, 2016
Management approaches for suspected and established Lyme disease used at the Lyme disease diagnostic center
Gary P Wormser, Donna McKenna, John Nowakowski
Wiener Klinische Wochenschrift
|
November 9, 2002
Duration of treatment for Lyme borreliosis: time for a critical reappraisal
Gary P Wormser, John Nowakowski, Robert B Nadelman
Journal of the American Academy of Nurse Practitioners
|
March 11, 2004
Factors influencing the utilization of Lyme disease-prevention behaviors in a high-risk population
Donna McKenna, Yolanda Faustini, John Nowakowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 9, 2003
Asymptomatic infection with Borrelia burgdorferi
Allen C Steere, Vijay K Sikand, Robert T Schoen, et al.
The American Journal of Medicine
|
December 3, 2014
Long-term assessment of fatigue in patients with culture-confirmed Lyme disease
Gary P Wormser, Erica Weitzner, Donna McKenna, et al.
Diagnostic Microbiology and Infectious Disease
|
October 13, 2017
The impact of strain-specific immunity on Lyme disease incidence is spatially heterogeneous
Camilo E Khatchikian, Robert B Nadelman, John Nowakowski, et al.
Infection and Immunity
|
January 15, 2014
Evidence for strain-specific immunity in patients treated for early lyme disease
Camilo E Khatchikian, Robert B Nadelman, John Nowakowski, et al.
The Journal of Antimicrobial Chemotherapy
|
April 13, 2010
Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis
Stephen Warshafsky, David H Lee, Louise K Francois, et al.
Clinical and Vaccine Immunology : CVI
|
August 22, 2008
Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease
Gary P Wormser, John Nowakowski, Robert B Nadelman, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
The New England Journal of Medicine
|
June 2, 2016
Therapy for Tuberculous Meningitis
Praveen Sudhindra, John Nowakowski
Wiener Klinische Wochenschrift
|
January 16, 2016
Management approaches for suspected and established Lyme disease used at the Lyme disease diagnostic center
Gary P Wormser, Donna McKenna, John Nowakowski
Wiener Klinische Wochenschrift
|
November 9, 2002
Duration of treatment for Lyme borreliosis: time for a critical reappraisal
Gary P Wormser, John Nowakowski, Robert B Nadelman
Journal of the American Academy of Nurse Practitioners
|
March 11, 2004
Factors influencing the utilization of Lyme disease-prevention behaviors in a high-risk population
Donna McKenna, Yolanda Faustini, John Nowakowski, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 9, 2003
Asymptomatic infection with Borrelia burgdorferi
Allen C Steere, Vijay K Sikand, Robert T Schoen, et al.
The American Journal of Medicine
|
December 3, 2014
Long-term assessment of fatigue in patients with culture-confirmed Lyme disease
Gary P Wormser, Erica Weitzner, Donna McKenna, et al.
Diagnostic Microbiology and Infectious Disease
|
October 13, 2017
The impact of strain-specific immunity on Lyme disease incidence is spatially heterogeneous
Camilo E Khatchikian, Robert B Nadelman, John Nowakowski, et al.
Infection and Immunity
|
January 15, 2014
Evidence for strain-specific immunity in patients treated for early lyme disease
Camilo E Khatchikian, Robert B Nadelman, John Nowakowski, et al.
The Journal of Antimicrobial Chemotherapy
|
April 13, 2010
Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis
Stephen Warshafsky, David H Lee, Louise K Francois, et al.
Clinical and Vaccine Immunology : CVI
|
August 22, 2008
Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease
Gary P Wormser, John Nowakowski, Robert B Nadelman, et al.
Page
of 4